156 related articles for article (PubMed ID: 31148199)
1. Loss of ZNF750 in ocular and cutaneous sebaceous carcinoma.
North JP; Solomon DA; Golovato J; Bloomer M; Benz SC; Cho RJ
J Cutan Pathol; 2019 Oct; 46(10):736-741. PubMed ID: 31148199
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
3. Loss of mismatch repair proteins in sebaceous gland tumors.
Popnikolov NK; Gatalica Z; Colome-Grimmer MI; Sánchez RL
J Cutan Pathol; 2003 Mar; 30(3):178-84. PubMed ID: 12641777
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
5. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
6. Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
Cheng AY; Lan J; Lee CH
J Dermatol; 2022 Jun; 49(6):600-606. PubMed ID: 35318716
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
8. Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumors.
Boecker W; Reusch M; Mielke V; Reusch U; Loening T; Tiemann M; Buchwalow I
J Dermatol; 2019 Mar; 46(3):249-258. PubMed ID: 30663115
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of survivin in cutaneous sebaceous lesions.
Calder KB; Khalil FK; Schlauder S; Cualing HD; Morgan MB
Am J Dermatopathol; 2008 Dec; 30(6):545-8. PubMed ID: 19033926
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B
J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813
[TBL] [Abstract][Full Text] [Related]
11. Loss of p21(WAF1) compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma.
McBride SR; Leonard N; Reynolds NJ
J Clin Pathol; 2002 Oct; 55(10):763-6. PubMed ID: 12354803
[TBL] [Abstract][Full Text] [Related]
12. Carcinoid-like pattern in sebaceous neoplasms: another distinctive, previously unrecognized pattern in extraocular sebaceous carcinoma and sebaceoma.
Kazakov DV; Kutzner H; Rütten A; Mukensnabl P; Michal M
Am J Dermatopathol; 2005 Jun; 27(3):195-203. PubMed ID: 15900121
[TBL] [Abstract][Full Text] [Related]
13. Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.
North JP; Golovato J; Vaske CJ; Sanborn JZ; Nguyen A; Wu W; Goode B; Stevers M; McMullen K; Perez White BE; Collisson EA; Bloomer M; Solomon DA; Benz SC; Cho RJ
Nat Commun; 2018 May; 9(1):1894. PubMed ID: 29760388
[TBL] [Abstract][Full Text] [Related]
14. Sebaceous carcinoma of the lung: histologic and immunohistochemical characterization of an unusual pulmonary neoplasm: report of a case and review of the literature.
Borczuk AC; Sha KK; Hisler SE; Mann JM; Hajdu SI
Am J Surg Pathol; 2002 Jun; 26(6):795-8. PubMed ID: 12023586
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis.
Xu S; Moss TJ; Laura Rubin M; Ning J; Eterovic K; Yu H; Jia R; Fan X; Tetzlaff MT; Esmaeli B
Mod Pathol; 2020 Jul; 33(7):1256-1263. PubMed ID: 31937901
[TBL] [Abstract][Full Text] [Related]
17. Rapidly growing extraocular sebaceous carcinoma occurring during pregnancy: a case report.
Ghosh SK; Bandyopadhyay D; Gupta S; Chatterjee G; Ghosh A
Dermatol Online J; 2008 Aug; 14(8):8. PubMed ID: 19061568
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphology of sebaceous carcinoma with analysis of p40 antibody expression.
Jain D; Mathur SR; Sharma MC; Iyer VK
Diagn Cytopathol; 2015 Jun; 43(6):456-61. PubMed ID: 25611456
[TBL] [Abstract][Full Text] [Related]
19. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
Harrington CR; Egbert BM; Swetter SM
Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
